Full-Time

Senior Associate Data Security Engineer

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Mid, Senior, Expert

Hyderabad, Telangana, India

Category
Cybersecurity
IT & Security
Required Skills
Salesforce
AWS
Linux/Unix
Requirements
  • Knowledge of Cloud Access Security Platforms (Elastica, Netskope, SkyHigh, etc)
  • Understanding of cloud and SAAS environments (AWS, O365, Box, Salesforce, etc)
  • Solid experience with potential to grow knowledge in Linux/Windows OS and other infrastructure systems
  • Experience with DLP and data protection technologies for a large global enterprise
  • Demonstrated understanding on how emerging security technologies and data flows interoperate across complex, multi-cloud systems.
  • Master’s degree and 1 to 3 years of experience OR Bachelor’s degree and 3 to 5 years of experience OR Diploma and 7 to 9 years of experience.
Responsibilities
  • Maintain the service delivery and working order of Amgen data security solutions across Amgen’s global enterprise
  • Execute Amgen service management processes such as Incident Management, change processes, and service improvements for Amgen’s data security technologies
  • Assist in the design and improvement of Amgen’s data security technologies and solutions. Build scripts for the configuration and the testing of the solution
  • Manage and perform analysis of escalated DLP events, engage with the business, fulfill legal hold requests, and provide executive reporting
  • Work with business domain specialists to collect, analyze, build, tune and automate DLP policy sets
  • Analyze events and logs for suspicious activity and opportunities to improve posture, processes, procedures, and protections.
  • Consult to the Incident Response team on investigations
  • Develop automation solutions in increase response times and reduce risk of identified incidents
  • Participate in regular meetings and conference calls with the client, IT, business partners and vendors to help ensure technical coverage for new or existing projects across the business.
Desired Qualifications
  • Comfort with scripting (PowerShell, Python, etc) and expression development (SQL, Regex)
  • Ability to develop documentation for Infrastructure Security implementations
  • Basic experience with ITIL processes such as Incident, Problem, and configuration management
  • Experience in complex enterprise environments with competing business priorities
  • Systems Security Certified Practitioner (SSCP) or Security+
  • SANS Certifications
  • Relevant vendor-specific certifications
  • Established analytical and gap/fit assessment skills.
  • Ability to work effectively with global, virtual teams
  • High degree of initiative and self-motivation.
  • Ability to manage multiple priorities successfully.
  • Team-oriented, with a focus on achieving team goals
  • Effective presentation and public speaking skills.

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are medicines made from living organisms. These therapies target conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The company's goal is to improve patient care by providing effective treatments for serious health conditions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Micromet boosts Amgen's oncology portfolio with BiTE antibody blinatumomab.
  • Institutional investments indicate strong confidence in Amgen's financial health and prospects.
  • Amgen's AI-driven drug discovery investments could accelerate R&D capabilities.

What critics are saying

  • Micromet acquisition may face clinical or regulatory challenges impacting strategic goals.
  • Investor pressure for short-term gains may affect long-term R&D investments.
  • FTC scrutiny on mergers could hinder Amgen's future strategic growth.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline in oncology, cardiovascular, and autoimmune disorders.
  • Amgen's strategic acquisitions enhance its innovative medicine portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

Amgen
Jun 2nd, 2025
Amgen to Acquire Micromet| Amgen

The acquisition includes blinatumomab, a Bispecific T cell Engager (BiTE) antibody in Phase 2 clinical development for acute lymphoblastic leukemia (ALL). Blinatumomab is also in clinical development for the treatment of non-Hodgkin's lymphoma (NHL), and could have applications in other hematologic malignancies.

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.